More Serious Adverse Events Seen With Debulking + Systemic Therapy in Metastatic CRC
FRIDAY, Oct. 20, 2023 (HealthDay News) — For patients with multiorgan metastatic colorectal cancer (mCRC), adding maximum tumor debulking to systemic therapy is associated with more serious adverse events but no difference in health-related quality o…
Learn MoreEstudio confirma riesgo de problemas gastrointestinales en consumidores de Wegovy y Ozempic
VIERNES, 6 de octubre de 2023 (HealthDay News) — Aunque muchos han elogiado los poderes de populares medicamentos para perder peso como Wegovy y Ozempic, una nueva investigación confirma que estos medicamentos pueden desencadenar efectos secundarios …
Learn MoreStudy Confirms Risk of Gastro Issues for People Taking Wegovy, Ozempic
THURSDAY, Oct. 5, 2023 (HealthDay News) — While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects.Known as GLP-1 agonists,…
Learn MoreStudy Confirms Risk of Gastro Issues for People Taking Wegovy, Ozempic
THURSDAY, Oct. 5, 2023 (HealthDay News) — While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects.Known as GLP-1 agonists,…
Learn MoreLa FDA agrega advertencia a la etiqueta de Ozempic sobre el riesgo de obstrucción intestinal
JUEVES, 28 de septiembre de 2023 (HealthDay News) — Ozempic, un medicamento para la diabetes tipo 2 que se ha utilizado cada vez más para ayudar en la pérdida de peso, ahora estará etiquetado como posible causante de obstrucción intestinal.La Adminis…
Learn MoreFDA Adds Warning to Ozempic Label About Risk for Blocked Intestines
WEDNESDAY, Sept. 27, 2023 (HealthDay News) — Ozempic will now be labeled as having the potential to block intestines. The U.S. Food and Drug Administration recently made the label update for the drug made by Novo Nordisk, without directly citing Ozem…
Learn MoreFDA Adds Warning to Ozempic Label About Risk for Blocked Intestines
WEDNESDAY, Sept. 27, 2023 (HealthDay News) — Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.The U.S. Food and Drug Administration recently made…
Learn MoreGene Test Spots Those Vulnerable to Rare but Severe Side Effect of Drugs for MS, Other Conditions
WEDNESDAY, Sept. 13, 2023 (HealthDay News) — A large number of drugs used to treat everything from multiple sclerosis to blood cancers to rheumatoid arthritis may cause a rare but often-fatal condition called progressive multifocal leukoencephalopath…
Learn MoreMitotane Not Needed With Low- to Intermediate-Risk Adrenocortical Carcinoma
TUESDAY, Sept. 5, 2023 (HealthDay News) — Mitotane does not show a significant improvement in the relapse rate and is associated with adverse events in patients with adrenocortical carcinoma considered to be at low-to-intermediate risk for recurrenc…
Learn MoreT-Cell Tolerant Fraction Can Predict Immunotherapy Toxicity
MONDAY, Aug. 21, 2023 (HealthDay News) — The T-cell tolerant fraction predicts clinically significant immune-related adverse events (irAEs) among patients with cancer treated with immune checkpoint inhibitors (ICIs), according to a study published in…
Learn More